Brittany Baur
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
32
Citations
431
Est. group size
—
Recurring co-author estimate
Active years
15
Publishing since 2011
Typically publishes in teams of ~7 · 31% small-team papers (≤3 authors) · across 16 venues
- 150MO Safety results from the phase IIIb SIERRA study of durvalumab (D) and tremelimumab (T) as first-line (1L) treatment (tx) for hepatocellular carcinoma (HCC) participants (pts) with a poor prognosis
Annals of Oncology · 2025
- 323P Early safety and efficacy from the phase IIIb TOURMALINE study of durvalumab (D) in combination with gemcitabine (G)-based chemotherapy in advanced biliary tract cancer (aBTC)
Annals of Oncology · 2025
- Real-world treatment patterns and challenges of patients with biliary tract cancer: retrospective chart review survey in Europe (GARNET-2)
ESMO Real World Data and Digital Oncology · 2024
- 133O Safety of 30 min infusion of durvalumab (D) in combination with gemcitabine (G)-based chemotherapy in first-line treatment (tx) of advanced biliary tract cancer (aBTC): TOURMALINE early results
Annals of Oncology · 2024
- Author Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
Scientific Reports · 2024
- Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
Scientific Reports · 2023
- Leveraging epigenomes and three-dimensional genome organization for interpreting regulatory variation
PLoS Computational Biology · 2023
- Benchmarking graph representation learning algorithms for detecting modules in molecular networks
F1000Research · 2023
- Dataset for Paper "Benchmarking graph representation learning algorithms for detecting modules in molecular networks"
Zenodo (CERN European Organization for Nuclear Research) · 2023
- 125P Real-world treatment patterns in patients with biliary tract cancer (BTC): Retrospective chart review survey in Europe (GARNET-2)
Annals of Oncology · 2023
- Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
Scientific Reports · 2023
- Abstract P1-13-23: Carboplatin resistance-associated changes in the 3D chromatin landscape of a triple-negative breast cancer Patient-Derived Xenograft
Cancer Research · 2023
- Comparison of deep and shallow graph representation learning algorithms for detecting modules in molecular networks
Zenodo (CERN European Organization for Nuclear Research) · 2023
- Source Code for Paper "Benchmarking graph representation learning algorithms for detecting modules in molecular networks"
Zenodo (CERN European Organization for Nuclear Research) · 2023
- Predicting patient-specific enhancer-promoter interactions
Cell Reports Methods · 2023
- Annals of Oncology×4
- Scientific Reports×3
- Zenodo (CERN European Organization for Nuclear Research)×3
- Frontiers in Genetics×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Li Chen
Biochemistry, Genetics and Molecular Biology · Indiana University
- Li Shen
Biochemistry, Genetics and Molecular Biology · Indiana University
- James Douglas Engel
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Fan Feng
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Ricardo D’Oliveira Albanus
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile